Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio Minerals NV is a Belgian biotechnology company specializing in the development and manufacturing of advanced nutraceuticals and dietary supplements. The company is best known for its proprietary ch-OSA (choline-stabilized orthosilicic acid) technology, marketed globally under the brand name BioSil. This patented complex is designed to stimulate the body's natural production of collagen, keratin, and elastin, targeting improvements in skin elasticity, hair thickness, nail strength, and bone density. Bio Minerals focuses on evidence-based health solutions, supporting its products with extensive clinical research and double-blind, placebo-controlled trials. The company operates as a research-driven entity, licensing its technology and distributing its products through a network of international partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biosil.